{
  "id": 2025,
  "text": "Moreover, the addition of CYFRA 21-1 did not significantly increase the sensitivity of SCC-Ag.CA 125: seven1779,1796,1811-1815 of the eight identified studies1779,1796,1801,1811-1815 suggested that LoE 2- rising serum CA 125 during follow-up may be coincident with or precede the clinical diagnosis or recurrent cervical cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Moreover, the addition of CYFRA 21-1 did not significantly increase the sensitivity of SCC-Ag.CA 125: seven1779,1796,1811-1815 of the eight identified studies1779,1796,1801,1811-1815 suggested that LoE 2- rising serum CA 125 during follow-up may be coincident with or precede the clinical diagnosis or recurrent cervical cancer.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有研究，随访期间血清CA 125水平的升高可能与宫颈癌临床复发的诊断同时发生，或早于临床复发的诊断。因此，血清CA 125水平的动态监测在宫颈癌复发的早期发现中可能具有一定的临床价值。然而，其具体敏感性和特异性仍需结合其他指标进一步评估。",
  "query": "在宫颈癌随访过程中，血清CA 125水平升高是否可能早于临床复发的诊断？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在宫颈癌随访过程中，血清CA 125水平升高是否可能早于临床复发的诊断？\n\n<reference text>: Moreover, the addition of CYFRA 21-1 did not significantly increase the sensitivity of SCC-Ag.CA 125: seven1779,1796,1811-1815 of the eight identified studies1779,1796,1801,1811-1815 suggested that LoE 2- rising serum CA 125 during follow-up may be coincident with or precede the clinical diagnosis or recurrent cervical cancer.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有研究，随访期间血清CA 125水平的升高可能与宫颈癌临床复发的诊断同时发生，或早于临床复发的诊断。因此，血清CA 125水平的动态监测在宫颈癌复发的早期发现中可能具有一定的临床价值。然而，其具体敏感性和特异性仍需结合其他指标进一步评估。"
}